Last reviewed · How we verify
RO-3201195
At a glance
| Generic name | RO-3201195 |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RO-3201195 CI brief — competitive landscape report
- RO-3201195 updates RSS · CI watch RSS